|
GMP Training Seminars
ComplianceNet, Inc. offers a
variety of GMP training courses to help your company achieve
compliance with federal and international regulations. We
regularly present seminars at international conferences.
Visit the Upcoming Events page
to see when the next course is scheduled. We
can also bring these courses to you. Instead of paying for
travel and lodging for only one or two employees to attend a
conference, why not custom tailor a training seminar to fit your
needs and let everyone attend in the comfort of your own
conference room? The
following courses are currently available. Customizations of
these courses or additional courses can also be arranged. Email
us for more information.
 |
API GMP
Compliance: Training on ICH Q7A. Focuses on
the specific, detailed FDA and international recommendations
on
how to apply GMPs that are missing from the more
generic Finished Products regulations.
|
 | Building
in Compliance, Analytical Laboratories: How to set
up an Analytical Laboratory so it can be fully GMP compliant,
yet still retain its efficiency. Differences are pointed
out for labs working on early phase clinical products vs.
marketed products.
|
 | Building
in Compliance, Process Development: How to ensure that
Process Development work can be captured in a GMP compliant
manner so it can be used to support product filing claims and
process validation.
|
 | 21
CFR Part 11 Compliance: How to apply the Electronic
Record and Electronic Signature regulations in your
environment and key pitfalls to avoid. Includes an
overview of the regulation and how it applies to various
applications, spreadsheets, network environments, etc.
|
|
FDA
on Training |
| Training and
Education are one of the best preventive and responsive
investments a firm can make!
Training should be an integral and
fundamental thread that holds the success of your firm’s
programs together to assure conformance to the act.
Be sure training programs reflect
current practices and procedures.
Keep abreast of what others may be
doing.
Steven Niedelman, FDA
Presentation at PDA
October 2002
|
|
 |